|
|
Sandrine Loubiere
Make an automatic search of the Sandrine Loubiere publications on PUBMED
Economist
Diploma :
Laboratory
INSERM UMR912-SE4S
sandrine.loubiere@inserm.fr
Tél. : +33 (0) 496102884
Fax : +33 (0) 496102899
Adresse : ORS PACA - UMR 912
23 rue Stanislas Torrents
13006 Marseille
France
Main current subjects of research :
-
Economics of Prevention
-
Access to antiretroviral treatment in developing countries
-
Therapeutic innovations in developed countries
-
Cost-effectiveness, cost-benefit analyses
-
HIV / AIDS, Hepatitis C, Co-infection
Main publications
-
Loubiere S, Peretti-Watel P, Boyer S, Blanche J, Abega SC, And Spire B. HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL Study. Social Science and Medicine 2009 69:885-91.
-
Loubiere S, Boyer S, Protopopescu C, Abe C, Abega SC, Spire B And Moatti JP. Decentralisation of HIV care in Cameroon: Increased access to antiretroviral treatment and associated persistent barriers. Health Policy 2009; 92: 165-73.
-
Loubiere S, Marhoum El Filal K, Sodqi M, Loundou A, Luchinni S, Cleary S, Moatti JP, Himmich H. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience. Antiviral Therapy 2008 13(2) :241 – 51.
-
Loubière S, Rotily M, Moatti JP. Prevention could be less cost-effective than cure : the case of HCV screening policies in France. International Journal of Technology Assessment in Health Care 2003;19(4):1-14.
-
Loubière S, Rotily M, Durand-Zaleski I, Costagliola D. Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective. Vox Sanguinis 2001; 80:199-204.
|
